Bluestem Biosciences files 24 patent applications
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
The settlement and dismissal resolves all claims between the parties
Silo enters into commercial evaluation license agreement for next generation liposomes
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
Includes thermostabilized Ebola vaccines
Subscribe To Our Newsletter & Stay Updated